iGMDRD133


Canonical SMILES: CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl

InChI: InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)

InChI Key: BCFGMOOMADDAQU-UHFFFAOYSA-N

Standard NameCHEMBLPubchem CIDKEGG Drug IDDRUGBANK IDDrug StatusDrug targets (TTD)Drug Type
LapatinibCHEMBL1201179 CHEMBL554 CHEMBL3526325 208908D08108DB01259AloneDCL000344Small Molecule




Drug Synonyms:

Lapatinib (INN)

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot


Gene IDGene NameModel Num.
123036TC2N1
55964SEPT31
3845KRAS4
250ALPP1
377007KLHL301
23221RHOBTB21
100130265ARL2BPP41
6597SMARCA41
83481EPPK11
2134EXTL11
4771NF211
23671TMEFF21
3195TLX11
4070TACSTD22
29943PADI11
2520GAST1
7158TP53BP11
55294FBXW71
4610MYCL1
25937WWTR11
3084NRG11
2707GJB31
4300MLLT31
51343FZR11
23217ZFR21
2064ERBB282
6850SYK1
472ATM1
22941SHANK21
642587MIR205HG1
2066ERBB415
94025MUC161
1029CDKN2A2
7157TP531
6794STK111
4292MLH11
100422595PCMTD1P32
8796SCEL1
106481809RN7SKP901
121506ERP271
81607NECTIN41
57111RAB251
4089SMAD42
8731RNMT3
5290PIK3CA2
105375355UPK3B1
1956EGFR2
4609MYC1
51321AMZ21
1031CDKN2C1
374286CDRT11
673BRAF1
7301TYRO31
2113ETS11
5122PCSK11
5728PTEN2
92949ADAMTSL11
5539PPY1
1974EIF4A21
53836GPR871
374918IGFL12
55785FGD61
6707SPRR32
54558SPATA61
1912PHC21
26525IL36RN1
1027CDKN1B1
9635CLCA22
101928337PTCSC22
84951TNS41
3872KRT171
5111PCNA1
10848PPP1R13L1
26287ANKRD21
3598IL13RA21
1825DSC31
5925RB11
4893NRAS1
2065ERBB34
7403KDM6A1
287ANK21
595CCND12
4763NF11
7022TFAP2C1
4613MYCN1
1499CTNNB11
106480676KRT8P512
5624PROC2
92747BPIFB11

Gene in drug-gene network: Network Plot

Models in Lapatinib

​​​​